About
Hormone Analogues for Rare Endocrine Diseases
Areas of Focus
Categories
Gene Therapy, RNA & Peptide TherapyMidwest
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
7
As Collaborator
0
Total Enrollment
363
By Phase
PHASE1: 4PHASE2: 3
By Status
RECRUITING: 4COMPLETED: 2ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT07142707Lead Sponsor
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity
PHASE1Recruiting
64 participants
Started: Sep 3, 2025 · Completed: May 30, 2026
NCT07029412Lead Sponsor
Study to Evaluate Efficacy and Dose Response of Imapextide (STEADI)
PHASE2Recruiting
10 participants
Started: Aug 26, 2025 · Completed: Jan 26, 2026
NCT06531941Lead Sponsor
Extension Study to Evaluate the Long-Term Safety and Tolerability of MBX 2109 in Patients With Hypoparathyroidism
PHASE2Recruiting
48 participants
Started: Oct 31, 2024 · Completed: May 27, 2027
NCT06465108Lead Sponsor
Safety, Pharmacokinetics and Efficacy of MBX 2109 in Patients With Hypoparathyroidism
PHASE2Active, not recruiting
64 participants
Started: Aug 8, 2024 · Completed: Jul 31, 2025
NCT06496217Lead Sponsor
Safety and Pharmacokinetics Study of MBX 2109 in Adult Subjects With Normal and Impaired Renal Function
PHASE1Recruiting
32 participants
Started: May 24, 2024 · Completed: Oct 12, 2024
Locations (1)
Headquarters
Carmel, IN, United States
Map
Loading map...